Table 1 Results of serial CSF and laboratory studies
From: Primary neurolymphomatosis with MAG antibody: a case report
April 2022 | January 2023 | Reference value | |
|---|---|---|---|
CSF cell count (×10^6/L) | 90 | 260 | < 5 |
CSF differential count | 95% monocyte 5% multinuclear cells | 90% monocyte 10% multinuclear cells | |
CSF protein (mg/L) | 4190.0 | 9210.0 | 150.0 ~ 450.0 |
CSF glucose (mmol/L) | 1.73 | 0.68 | 2.50 ~ 4.4 |
CSF IgG (mg/L) | 720.0 | 1250.0 | 0.0 ~ 30.0 |
CSF IgA (mg/L) | 108.0 | 177.0 | 0 ~ 11.10 |
CSF IgM ( mg/L) | 57.80 | 59.70 | 0 ~ 6.94 |
QIgG | - | 1.48 | < 0.85 |
QIgA | - | 1.03 | < 0.65 |
QIgM | - | 0.98 | < 0.55 |
OCB | - | Negative | Negative |
Serum MAG antibody | 1:320 | 1:1000 | Negative |
Monoclonal immunoglobulin | Negative | Negative | Negative |